6 Results for "

PAPD5

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "PAPD5" in MCE Product Catalog:

Cat. No.: HY-137817
CAS No.: 384859-58-9
Purity:  98.83%
Target:  

DNA/RNA Synthesis

Research Areas:  

Metabolic Disease

BCH001, a quinoline derivative, is a specific PAPD5 inhibitor. BCH001 restores telomerase activity and telomere length in dyskeratosis congenita (DC) induced pluripotent stem cells. BCH001 shows no inhibition of poly(A)-specific ribonuclease (PARN) or several other canonical and non-canonical polynucleotide polymerases. BCH001 is used to regulate aging .
loading...
    loading...
Cat. No.: HY-162327
Research Areas:  

Infection

PROTAC PAPD5 degrader 1 is a selective PAPD5 PROTAC degrader. PROTAC PAPD5 degrader 1 induces ubiquitination and degradation of PAPD5 without causing degradation of PAPD7. PROTAC PAPD5 degrader 1 reduces Hepatitis B virus mRNA and Hepatitis B surface antigen levels in vitro. PROTAC PAPD5 degrader 1 inhibits both Hepatitis A virus and Hepatitis B virus. PROTAC PAPD5 degrader 1 can be used for research on Hepatitis A virus infection and Hepatitis B virus infection .
loading...
    loading...
Cat. No.: HY-175913
Research Areas:  

Others

PAPD5 ligand-1 is a PAPD5 ligand, which can be used for the synthesis of PROTACs, such as PROTAC PAPD5 degrader 1 (HY-162327) .
loading...
    loading...
Cat. No.: HY-163149
CAS No.: 2226178-35-2
Target:  

HBV

Research Areas:  

Infection

AB-452, a Dihydroquinolizinone (DHQ) analogue, is a potent and orally active HBV RNA destabilizer. AB-452 inhibits PAPD5/7 proteins in vitro with good in vivo efficacy in a chronic HBV mouse model .
loading...
    loading...
Cat. No.: HY-159987
CAS No.: 2848560-66-5
Target:  

HBV

Research Areas:  

Infection

AB-161 is an orally active HBV RNA destabilizer and a PAPD5/7 inhibitor, with its primary action focused in the liver. AB-161 treats Hepatitis B Virus (HBV) infection by lowering the levels of Hepatitis B surface antigen (HBsAg), with an EC50 value of 2.2 nM for HBsAg. AB-161 can be used in the field of HBV infection research .
loading...
    loading...
Cat. No.: HY-181347
CAS No.: 2346450-55-1
Target:  

HBV

Research Areas:  

Infection

GLPG3808 is an orally active PAPD5/7 inhibitor. GLPG3808 inhibits the expression of HBcAg in various cells infected with HBV. GLPG3808 reduces the hepatitis B surface antigen levels in HBV-infected animal models. GLPG3808 can be used for the research of hepatitis B virus infection .
loading...
    loading...